Both hesperetin and naringenin effectively suppressed lung carcinoma and the associated preneoplastic lesions in a BaP-induced model by decreasing the expression of NF-kB, PCNA and CYP1A1 [71,110]. The gene discussed is PCNA; the disease is lung carcinoma.